Poor Performance Status, Diabetes Mellitus, and Statin use are Risk Factors for Decreased Skeletal Muscle Mass During Nab-paclitaxel Plus Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer.
期刊介绍:
Pancreas provides a central forum for communication of original works involving both basic and clinical research on the exocrine and endocrine pancreas and their interrelationships and consequences in disease states. This multidisciplinary, international journal covers the whole spectrum of basic sciences, etiology, prevention, pathophysiology, diagnosis, and surgical and medical management of pancreatic diseases, including cancer.